Why The GLP-1 Legacy Was Written A new book, The GLP-1 Legacy , was written to address the void that exists around the often non-existent aftercare required to help users transition off GLP-1s, whilst not regaining the lost weight
In Phase 2 trials, retatrutide produced approximately 24% mean weight loss at 48 weeks at 12 mg, compared with about 22.5% for tirzepatide at 15 mg in the SURMOUNT-1 trial though direct head-to-head data is not yet available
Summary: Ozempic does not directly cause sore throat as a recognised pharmacological side effect, though some patients report throat discomfort potentially linked to indirect mechanisms such as gastro-oesophageal reflux or nausea
Grech O, Mitchell JL, Lyons HS, et al
Skin tightening handles remodeling